REFERENCES
- He , Q. , Wang , N. , Skog , S. , Ericsson , S. and Tribukait , B. 1996 . Characterisation of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation . Europ. J. Cell Biol. , 70 : 117 – 124 .
- Wu , C. , Yang , R. , Zhou , J. , Bao , S. , Zou , L. , Mao , Y. and He , Q. 2003 . Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1 . J. Immuno. Method , 277 : 157 – 169 .
- He , Q. , Zou , L. , Zhang , P. , Liu , J. , Skog , S. and Fonander , T. 2000 . The clinical significance of thymidine kinase 1 measurement in serum of breast cancer patients using anti-TK1 antibody . Internal. J. Biol. Marker , 15 : 139 – 146 .
- Greene , F. L. , Page , D. L. Fleming , I. D. 2002 . AJCC Cancer Staging Manual Springer-Verlag, New York
- Guan , H. , Sun , Y. , Zan , Q. , Xu , M. , Li , Y. , Zhou , J. , He , E. , Eriksson , S. , Wen , W. and Skog , S. 2009 . Thymidine kinase 1 expression in atypical ductal hyperplasia significantly differs from usual ductal hyperplasia and ductal carcinoma in situ: a useful tool in tumour therapy management . Mol. Med. Reports , 2 : 923 – 929 .
- HengZhi , C. , Zhou , H. , Tian , N. B. , He , E. and Skog , S. 2008 . Serological thymidine kinase 1 (STK1) indicate an elevated risk for development of malignant tumors . Anticancer Res. , 28 : 3897 – 3908 .
- Xing-Hua , Z. , Jin-Rong , Y. , Xian-Yan , F. , Lei , Q. , Hai-Yin , L. , Hai-Xia , W. , Xia , Y. , Bo , S. , Ming , Z. , He , E. and Skog , S. 2010 . “ The significance of serum thymidine kinase 1 for the risk screening of cancer development of pre-cancerous diseases–an analysis of the Jilin Oilfield 8869 healthy screening ” . 35 – 38 . Chin. J. Health Manage, 4
- He , Q. , Fornander , T. , Johansson , H. , Johansson , U. , Hu , G. Z. , Rutqvist , L. E. and Skog , S. 2006 . Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer . Anticancer Res. , 26 : 4753 – 4759 .
- Topolan , O. and Holubec , L. 2008 . The role of thymidine kinase in cancer disease . Expert Opinion , 2 : 129 – 141 .
- Broet , P. , Romain , S. Daver , A. 2000 . Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients . J. Clin. Oncol. , 19 : 2778 – 2787 .